Drug recall · December 12, 2018
Amlodipine and Olmesartan Medoxomil Tablets recall
Why: Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30
- Lots / codes
Lot#: OWSA18002-A, Exp 7/2020
- Quantity
- 4464 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- November 30, 2018 · Voluntary: Firm initiated
- Classified
- December 6, 2018
- Reported
- December 12, 2018
- Ended
- February 1, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine / olmesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.